COVID and flu combo test study
Part of Infections, Lungs & breathing clinical trials.
This study is testing a rapid test that can tell if you have COVID-19 or the flu from a single nose swab. It is for people who are in the first 5 days of feeling sick with two or more symptoms like fever, cough, or sore throat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old.
- You have two or more symptoms like fever, cough, fatigue, or sore throat.
- Your symptoms started in the last 5 days.
- You haven't tested positive for COVID-19 in the last 45 days.
- You haven't had a nasal vaccine (like FluMist) in the past 30 days.
- You haven't taken antiviral flu or COVID-19 treatments in the last 45 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial is testing a new at-home test for respiratory infections like the flu and COVID-19. The test is done by you or a caregiver using a nose swab. It may help you get quick and accurate results without going to a clinic.
This trial evaluates a new test that can detect flu A/B, RSV, and COVID-19 from a single nose swab. It is for people who are currently sick with respiratory symptoms and are either hospitalized, in the ER, visiting a clinic, or living in a long-term care facility.
This study is testing a new, easy-to-use COVID-19 test called the Metrix COVID-19 Test. If you have a fever or other cold or flu-like symptoms today, you may help confirm if this test works well.
This study tests a breathalyzer device that quickly detects COVID-19, flu, and RSV from your breath. If you are already being tested for these viruses, you may join to see if this new method works as well as the usual swab test.
This trial tests whether using a fast, bedside PCR test (which quickly identifies the virus or bacteria causing your illness) can help doctors choose the right treatment sooner for adults admitted to the hospital with a respiratory infection like pneumonia or flu. It aims to improve care by tailoring antibiotics or antivirals to the specific cause.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.